Description
Latin name
Rinorus
Release form
Nasal spray
Packing
Bottle of 10 ml.
Pharmacological action
Rinorus – belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, eliminating edema and hyperemia of the nasal mucosa, restores patency of the nasal passages, facilitates nasal breathing.
The action of the drug occurs a few minutes after its use and lasts up to 10 hours
Indications
acute rhinitis (including for acute respiratory diseases)
allergic rhinitis (if there is no allergy to eucalyptus oil)
sinusitis (sinusitis, frontal sinusitis)
otitis media (as part of combination therapy to reduce swelling of the mucosa) .
Composition
1 ml contains:
Active ingredient:
xylometazoline hydrochloride 1 mg
Excipients: benzalkonium chloride, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, sodium hydrogen phosphate dodecahydrate, eucalyptus oil, water d / i.
Dosage and administration
Adults and children over 6 years of age are given 2-3 injections of 0, Rinorus 1% solution in each nasal passage 3-4 times a day.
Do not use more than 3 times a day.
Do not use the drug without a break for more than 3-5 days.
Side effects
Local reactions: with frequent and / or prolonged use – irritation and / or dryness of the mucous membrane of the nasopharynx, burning, paresthesia, sneezing, hypersecretion rarely – swelling of the nasal mucosa.
Systemic reactions: vomiting, headache, palpitations, increased blood pressure, insomnia, visual impairment, depression (with prolonged use of high doses).
Drug Interactions
It is possible to enhance systemic effects while using MAO inhibitors and tricyclic antidepressants.
Overdose of
Symptoms: increased side effects.
Treatment: symptomatic under medical supervision.
Storage Conditions
In a dry, dark place at 15 to 25 ° C.
Active ingredient
Xylometazoline
Form of Treatment
spray nazalyn y
vasoconstrictor
Synthesis AKOMP, Russia
